Your results for

Filter by

Filter by
Results

Filter by

Content type
Key content topics
Key audience
Top cancer treatments

Clinical experience from the first compact IMPT Proton Therapy Center: the advantages of treating in an open gantry environment

26/01/2018
/ Event
/
IMPT

The Willis-Knighton Health System, headquartered in Shreveport, Louisiana, is a not-for-profit community healthcare corporation with four general acute care...

Renal function in abdominal neuroblastoma patients undergoing proton radiotherapy.

12/01/2023
/ Publications
/
Chemotherapy
Toxicity

This study examined the renal function of 30 children with abdominal neuroblastoma treated with PT. With a median follow-up 35 months, there was no patients...

Gastrointestinal cancer & Proton Therapy

24/02/2023
/ Webinar

Jim Metz presents the rationale behind using proton therapy for gastrointestinal tumors. In this insightful presentation, he focuses on esophageal cancer...

Proton beam radiotherapy versus transarterial chemoembolization for hepatocellular carcinoma: Results of a randomized clinical trial.

05/09/2023
/ Publications
/
Clinical Trial

Published by the Loma Linda group, this study reported the results of their randomized trial compared PBT with TACE for HCC. Patients were randomized to receive...

Clinical outcomes and factors involved in the local control of proton beam therapy for oligometastatic liver tumors in patients with colorectal cancer.

01/03/2024
/ Publications

This study reported outcomes of 41 patients with colorectal cancer liver metastases (63 lesions) treated with PBT to a total dose of 72.6 GyRBE in 22 fractions...

Outcomes of Patients Treated in the UK Proton Overseas Programme: Non-central Nervous System Group.

01/03/2024
/ Publications

This report presented the results of patients with non-CNS malignancies treated in the UK proton overseas program. Four hundred and ninety-five patients were...

Gastrointestinal bleeding/ulcer among paediatric cancer patients after proton beam therapy.

13/06/2023
/ Publications
/
Reirradiation
Chemotherapy

This study analyzed 124 patients who underwent proton therapy with gastrointestinal tract involved in the irradiated field. The study reported gastrointestinal...

Image-Guided Proton Therapy for Elderly Patients with Hepatocellular Carcinoma: High Local Control and Quality of Life Preservation.

16/12/2021
/ Publications
/
Quality of life

This study reported the efficacy and safety of image-guided proton therapy (IGPT) for elderly (≥80 years old) hepatocellular carcinoma (HCC) patients. Seventy...

Long-term clinical outcomes of patients receiving proton beam therapy for caudate lobe hepatocellular carcinoma.

16/07/2021
/ Publications
/
Clinical Trial

Thirty patients with caudate lobe HCC were treated to a total doses of 55 to 77 (median 72.6) GyRBE. The median follow-up period was 37.5 months. The OS rates...

A phase II trial of hypofractionated high-dose proton beam therapy for unresectable liver metastases.

16/11/2022
/ Publications
/
Dosimetry
Toxicity

This study analyzed 46 patients with 49 liver metastases treated by PBT to a total dose of 60 GyRBE in 5 fractions (BED 132 GyE) or 70 GyRBE in 10 (BED 119 GyE)...